Cargando…

Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery

The aim of this study was to identify prognostic factors affecting intrahepatic progression-free survival (ihPFS) and overall survival (OS) in patients with colorectal cancer liver metastases (CRCLM) undergoing portal vein embolization (PVE) and subsequent (extended) right hemihepatectomy. A total o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hitpass, Lea, Heise, Daniel, Schulze-Hagen, Maximilian, Pedersoli, Federico, Ulmer, Florian, Amygdalos, Iakovos, Isfort, Peter, Neumann, Ulf, Kuhl, Christiane, Bruners, Philipp, Zimmermann, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352622/
https://www.ncbi.nlm.nih.gov/pubmed/32575781
http://dx.doi.org/10.3390/cancers12061638
_version_ 1783557681058938880
author Hitpass, Lea
Heise, Daniel
Schulze-Hagen, Maximilian
Pedersoli, Federico
Ulmer, Florian
Amygdalos, Iakovos
Isfort, Peter
Neumann, Ulf
Kuhl, Christiane
Bruners, Philipp
Zimmermann, Markus
author_facet Hitpass, Lea
Heise, Daniel
Schulze-Hagen, Maximilian
Pedersoli, Federico
Ulmer, Florian
Amygdalos, Iakovos
Isfort, Peter
Neumann, Ulf
Kuhl, Christiane
Bruners, Philipp
Zimmermann, Markus
author_sort Hitpass, Lea
collection PubMed
description The aim of this study was to identify prognostic factors affecting intrahepatic progression-free survival (ihPFS) and overall survival (OS) in patients with colorectal cancer liver metastases (CRCLM) undergoing portal vein embolization (PVE) and subsequent (extended) right hemihepatectomy. A total of 59 patients (mean age: 60.8 ± 9.3 years) with CRCLM who underwent PVE in preparation for right hemihepatectomy were included. IhPFS and OS after PVE were calculated using the Kaplan–Meier method. Cox regression analyses were conducted to investigate the association between the following factors and survival: patient age, laterality of the colorectal cancer (right- versus left-sided), tumor location (colon versus rectal cancer), time of occurrence of hepatic metastases (synchronous versus metachronous), baseline number and size of hepatic metastases, presence or absence of metastases in the future liver remnant (FLR) before PVE, preoperative carcinoembryogenic antigen (CEA) levels, time between PVE and surgery, history of neoadjuvant or adjuvant chemotherapy, and the presence or absence of extrahepatic disease before PVE. Median follow up was 18 months. The median ihPFS was 8.2 months (95% confidence interval: 6.2–10.2 months), and median OS was 34.1 months (95% confidence interval: 27.3–40.9 months). Laterality of the primary colorectal cancer was the only statistically significant predictor of ihPFS after PVE (hazard ratio (HR) = 2.242; 95% confidence interval: 1.125, 4.465; p = 0.022), with patients with right-sided colorectal cancer having significantly shorter median ihPFS than patients with left-sided cancer (4.0 ± 1.9 months versus 10.2 ± 1.5 months; log rank test: p = 0.018). Other factors, in particular also the presence or absence of additional metastases in the FLR, were not associated with intrahepatic progression-free survival. The presence of extrahepatic disease was associated with worse OS (HR = 3.050, 95% confidence interval: 1.247, 7.459; p = 0.015).
format Online
Article
Text
id pubmed-7352622
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73526222020-07-21 Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery Hitpass, Lea Heise, Daniel Schulze-Hagen, Maximilian Pedersoli, Federico Ulmer, Florian Amygdalos, Iakovos Isfort, Peter Neumann, Ulf Kuhl, Christiane Bruners, Philipp Zimmermann, Markus Cancers (Basel) Article The aim of this study was to identify prognostic factors affecting intrahepatic progression-free survival (ihPFS) and overall survival (OS) in patients with colorectal cancer liver metastases (CRCLM) undergoing portal vein embolization (PVE) and subsequent (extended) right hemihepatectomy. A total of 59 patients (mean age: 60.8 ± 9.3 years) with CRCLM who underwent PVE in preparation for right hemihepatectomy were included. IhPFS and OS after PVE were calculated using the Kaplan–Meier method. Cox regression analyses were conducted to investigate the association between the following factors and survival: patient age, laterality of the colorectal cancer (right- versus left-sided), tumor location (colon versus rectal cancer), time of occurrence of hepatic metastases (synchronous versus metachronous), baseline number and size of hepatic metastases, presence or absence of metastases in the future liver remnant (FLR) before PVE, preoperative carcinoembryogenic antigen (CEA) levels, time between PVE and surgery, history of neoadjuvant or adjuvant chemotherapy, and the presence or absence of extrahepatic disease before PVE. Median follow up was 18 months. The median ihPFS was 8.2 months (95% confidence interval: 6.2–10.2 months), and median OS was 34.1 months (95% confidence interval: 27.3–40.9 months). Laterality of the primary colorectal cancer was the only statistically significant predictor of ihPFS after PVE (hazard ratio (HR) = 2.242; 95% confidence interval: 1.125, 4.465; p = 0.022), with patients with right-sided colorectal cancer having significantly shorter median ihPFS than patients with left-sided cancer (4.0 ± 1.9 months versus 10.2 ± 1.5 months; log rank test: p = 0.018). Other factors, in particular also the presence or absence of additional metastases in the FLR, were not associated with intrahepatic progression-free survival. The presence of extrahepatic disease was associated with worse OS (HR = 3.050, 95% confidence interval: 1.247, 7.459; p = 0.015). MDPI 2020-06-20 /pmc/articles/PMC7352622/ /pubmed/32575781 http://dx.doi.org/10.3390/cancers12061638 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hitpass, Lea
Heise, Daniel
Schulze-Hagen, Maximilian
Pedersoli, Federico
Ulmer, Florian
Amygdalos, Iakovos
Isfort, Peter
Neumann, Ulf
Kuhl, Christiane
Bruners, Philipp
Zimmermann, Markus
Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery
title Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery
title_full Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery
title_fullStr Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery
title_full_unstemmed Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery
title_short Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery
title_sort primary tumor location is a prognostic factor for intrahepatic progression-free survival in patients with colorectal liver metastases undergoing portal vein embolization as preparation for major hepatic surgery
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352622/
https://www.ncbi.nlm.nih.gov/pubmed/32575781
http://dx.doi.org/10.3390/cancers12061638
work_keys_str_mv AT hitpasslea primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT heisedaniel primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT schulzehagenmaximilian primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT pedersolifederico primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT ulmerflorian primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT amygdalosiakovos primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT isfortpeter primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT neumannulf primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT kuhlchristiane primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT brunersphilipp primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery
AT zimmermannmarkus primarytumorlocationisaprognosticfactorforintrahepaticprogressionfreesurvivalinpatientswithcolorectallivermetastasesundergoingportalveinembolizationaspreparationformajorhepaticsurgery